OakChart

Ainos Inc

AIMDTechnology·Scientific & Technical Instruments·USA·Nano·NASD·Nov 11 • 1:19 PM ET

0.4701+0.0008 (0.17%)
2026-11-11 19:22 CET
Market cap
3.47 USD m
Revenue, TTM
0.01 USD m
Net income, TTM
-14.45 USD m
Free cash flow, TTM
-4.49 USD m
EPS diluted, TTM
-2.53
P/E
-
Compare

Price

AIMD against its 20, 50 and 200-day averages
2050200earnings
1.002.003.004.008.6M17.2MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26AIMDclose 0.4720-day 0.7450-day 1.11200-day 1.550.4752w high

87.9% under the 52-week high of 3.88 on 26 May 2026. 52-week low 0.43 on 11 Nov 2026. Last 15 sessions, 123.0% high to low

Profile

AIMD
52-week range, 0% of the way up
0.463.88

Ainos, Inc. operates as a dual-platform biotech company, which engages in the development of artificial intelligence-enabled olfactory sensing technologies and immune therapeutics. The firm primarily focuses on the commercialization of AI Nose, an AI-based electronic olfaction system. It continues to develop VELDONA, a low-dose oral interferon platform. The company was founded on June 26, 1984 and is headquartered in Houston, TX.

Employees41
IPOAug 08, 1996
Beta2.72
ATR, 14d0.11
Rel volume0.72
Short float2.05%
Insider own75.20%
Inst own2.36%

Snapshot

6 groups

Valuation

Index-
Market Cap3.48M
Enterprise Value15.87M
Income-14.45M
Sales0.01M
Book/sh0.44
Cash/sh0.19
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees41
IPOAug 08, 1996

Ratios

P/E-
Forward P/E-
PEG-
P/S347.59
P/B1.06
P/C2.45
P/FCF-
EV/EBITDA-
EV/Sales1586.59
Quick Ratio0.12
Current Ratio0.13
Debt/Eq4.21
LT Debt/Eq0.00
Option/ShortNo / Yes

Earnings

EPS (ttm)-2.53
EPS next Y-
EPS next Q-
EPS this Y-
EPS next Y-
EPS next 5Y-
EPS past 3/5Y48.74% 23.68%
Sales past 3/5Y-67.20% 49.61%
EPS Y/Y TTM51.12%
Sales Y/Y TTM-87.73%
EPS Q/Q36.98%
Sales Q/Q-96.74%
Earnings-
EPS/Sales Surpr.- -

Ownership

Insider Own75.20%
Insider Trans-3.27%
Inst Own2.36%
Inst Trans8.45%
ROA-66.48%
ROE-196.30%
ROIC-440.15%
Gross Margin-34987.54%
Oper. Margin-101210.17%
Profit Margin-106283.32%
SMA20-36.72%
SMA50-57.66%
SMA200-69.59%
Trades-

Technical

Shs Outstand7.38M
Shs Float1.83M
Short Float2.05%
Short Ratio0.27
Short Interest0.04M
52W High3.88 -87.88%
52W Low0.46 1.64%
Volatility24.78% 15.97%
ATR (14)0.11
RSI (14)24.53
Beta2.72
Rel Volume0.72
Avg Volume139.75K
Volume61,721

Performance

Perf Week-35.64%
Perf Month-56.47%
Perf Quarter-67.35%
Perf Half Y-72.51%
Perf YTD-71.34%
Perf Year-84.93%
Perf 3Y-97.06%
Perf 5Y-99.82%
Perf 10Y-99.37%
Recom-
Target Price-
Prev Close0.47
Price0.47
Change %0.17%

Peers

Mkt cap
TickerCompanyMkt cap
ASTCAstrotech Corp9.24M
FCUVFocus Universal Inc3.10M
MSAIMultiSensor AI Holdings Inc7.20M
LINKInterlink Electronics54.20M
ACFNAcorn Energy Inc38.60M
ARBEArbe Robotics Ltd65.29M
MVISMicrovision Inc40.17M
SVRESaverOne 2014 Ltd ADR1.71M
MINDMIND Technology Inc27.99M
SOTKSono-Tek Corp68.99M

Insider trading

latest 14 of 18
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
chiang yao-chungDirectorJun 05 '26Buy2.053,5007,17511,279Jun 09 12:04 PM
chiang yao-chungDirectorJun 03 '26Buy2.132,0004,2607,779Jun 05 04:10 PM
chiang yao-chungDirectorMay 28 '26Buy2.302505755,779Jun 01 04:10 PM
chiang yao-chungDirectorMay 27 '26Buy2.002,0004,0005,529May 29 04:10 PM
lee ting-chuanDirectorMay 26 '26Sale1.90109,988208,977807,417May 27 08:02 PM
Taiwan Carbon Nano Technology10% OwnerMay 26 '26Sale2.3641,00096,760948,925May 27 08:00 PM
TSAI CHUN-JUNGDirectorMay 26 '26Sale1.8727,71851,833658,199May 27 07:58 PM
TSAI CHUN-JUNGDirectorMay 22 '26Sale1.551,0821,677685,917May 27 07:58 PM
lee ting-chuanDirectorMay 22 '26Sale1.579,30214,604917,405May 26 04:10 PM
lee ting-chuanDirectorMay 21 '26Sale1.569,00014,040926,707May 26 04:10 PM
chiang yao-chungDirectorMay 19 '26Buy1.682,2003,6963,529May 20 04:10 PM
chiang yao-chungDirectorMay 18 '26Buy1.655008251,329May 20 04:10 PM
chiang yao-chungDirectorMay 05 '26Buy1.70129219829May 07 04:10 PM
chiang yao-chungDirectorApr 30 '26Buy1.68200336700May 01 04:10 PM

Held by

AUM
TickerCompanyAUM
VXFVanguard Extended Market Index ETFAUM: 30.47B

News

latest 14 of 200
  • Ainos Surpasses 3 Billion Real-World Chemical Data Points, Advancing Chemical Intelligence for Smart Factories (ACCESSWIRE) -13.77%
  • Ainos Completes VELDONA Technology Transfer, Triggering $600,000 License Payment (ACCESSWIRE)
  • Ainos Completes Delivery of 1,400 AI Nose Systems to ASE Under $2.1 Million, Three-Year Contract (ACCESSWIRE) -6.77%
  • Ainos Details Partner-Funded VELDONA Development and Revenue Opportunities, Reinforcing Focus on Chemical Intelligence (ACCESSWIRE)
  • Ainos and BioPhoenix Sign VELDONA License Agreement, Establishing a Potential $10 Million Collaboration Framework (ACCESSWIRE)
  • VASRO Research Highlights Ainos' New Order, Semiconductor Commercial Momentum and 1 Billion+ Chemical Dataset (ACCESSWIRE)
  • Ainos Shares Rise 6.9% After Receiving Initial AI Nose Semiconductor Orders (InvestorsHub)
  • Ainos Advances AI Nose into Commercial Deployment in Front-End Semiconductor Manufacturing (ACCESSWIRE)
  • Ainos Secures Three Japanese Robotics Patents, Advancing Chemical Perception for the Physical AI Era (ACCESSWIRE)
  • Ainos Launches Atmosphere Engine, Extending Physical AI from Environmental Sensing to Active Environmental Management (ACCESSWIRE) +5.71%
  • Ainos Unveils Next-Generation AI Nose, Advancing the Infrastructure for Chemical Intelligence (ACCESSWIRE)
  • Ainos Surpasses 878 Million Real-World Data Points, Up 43% in 23 Days as 1,400-System AI Nose Semiconductor Deployment Advances (ACCESSWIRE)
  • Ainos to Showcase Environmental Intelligence for Physical AI at SEMICON Taiwan 2026 (ACCESSWIRE)
  • VASRO Research Highlights Ainos' Progress in Scaling Smell AI Commercialization and Compounding Its Smell ID Dataset (ACCESSWIRE)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q12026-05-13---0.00--
2025Q32025-11-13---0.00--
2025Q22025-08-13---0.00--
2025Q12025-05-12---0.2100.11--
2024Q12024-05-13---0.5700.02--
2023Q32023-11-13---0.1500.02--
2023Q22023-08-11---0.1200.03--
2022Q22022-08-16---0.0100.64--

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2012FY-71.250--71.2500.00-

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
No estimate revisions.

Estimate history

EPS, annual-11.25-14.085-14.865-13.354-12.874-25.677-16.801-7.82-3.459-2.5295
Period201720182019202020212022202320242025TTM
EPS, quarterly-2.451-1.64-1.508-1.036-0.991-0.644-0.853-0.408-0.625
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Sales, annual0.2510.0780.0120.0170.5953.520.1220.0210.1240.01
Period201720182019202020212022202320242025TTM
Sales, quarterly0000.1060.0050.0020.01100
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Shares, annual0.0620.1040.1080.1120.3850.80.9363.0855.8837.384
Period201720182019202020212022202320242025MRQ
Shares, quarterly1.4782.7633.0853.4434.2684.7945.8836.1067.384
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue0.010.120.020.123.520.590.020.010.08
Cost of Goods Sold Incl. D&A4.774.804.855.236.932.220.030.030.12
Gross Profit-4.76-4.68-4.83-5.11-3.41-1.62-0.01-0.02-0.04
Selling, General and Administrative Excl. Other9.019.319.017.8110.572.251.431.561.29
Research and Development6.467.758.417.032.031.920.000.050.03
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-13.76-13.99-13.84-12.92-13.98-3.87-1.44-1.58-1.33
Interest Expense0.730.710.620.140.050.020.010.000.00
Unusual Expense0.000.000.580.720.000.000.00--
Net Income Before Taxes-14.45-14.77-14.86-13.77-14.01-3.89-1.45-1.58-1.34
Income Taxes0.000.000.000.000.000.000.000.000.00
Consolidated Net Income-14.45-14.77-14.86-13.77-14.01-3.89-1.45-1.58-1.34
Net Income From Continuing Operations-14.45-14.77-14.86-13.77-14.01-3.89-1.45-1.58-1.34
Net Income-14.45-14.77-14.86-13.77-14.01-3.89-1.45-1.58-1.34
EPS (Recurring)-1.96-3.46-7.60-16.19-25.68-12.87-13.36-14.86-14.08
EPS (Basic, Before Extraordinaries)-2.53-3.46-7.82-16.80-25.68-12.87-13.35-14.87-14.09
EPS (Diluted)-2.53-3.46-7.82-16.80-25.68-12.87-13.35-14.87-14.09
EBITDA-9.00-9.21-9.04-8.07-9.16-1.84-1.43-1.56-1.28
Non-Operating Income (Expense)0.04-0.070.180.010.02-0.000.000.000.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense-1.372.800.886.420.370.360.360.00
Price To Sales Ratio1,049.4856.41209.0668.802.40160.04418.251,020.28123.82
Gross Margin-34,987.54-3,767.20-23,317.97-4,181.56-96.84-272.69-56.83-164.37-55.77
Operating Margin-101,210.17-11,268.32-66,772.17-10,580.14-397.09-650.47-8,696.70-13,472.11-1,717.20
Net Margin-106,283.32-11,897.04-71,702.26-11,276.98-397.96-654.04-8,758.21-13,479.65-1,722.30
Shares Outstanding7.385.883.090.940.800.390.110.110.10
Market Capitalization3.473.477.038.3212.08121.287.1512.1510.56

Income statement, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q12024Q42024Q3
Total Revenue0.000.000.010.000.000.110.000.00
Cost of Goods Sold Incl. D&A1.191.171.201.211.201.200.000.00
Gross Profit-1.19-1.17-1.19-1.20-1.19-1.090.00-0.00
Selling, General and Administrative Excl. Other3.211.113.111.582.562.074.633.04
Research and Development1.851.102.121.391.911.722.332.02
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-4.40-2.28-4.30-2.78-3.75-3.16-4.63-3.04
Interest Expense0.200.180.180.180.180.180.180.26
Unusual Expense0.000.000.000.000.000.000.000.35
Net Income Before Taxes-4.59-2.46-4.47-2.93-4.08-3.29-4.65-3.70
Income Taxes0.000.000.000.000.000.000.000.00
Consolidated Net Income-4.59-2.46-4.47-2.93-4.08-3.29-4.65-3.70
Net Income From Continuing Operations-4.59-2.46-4.47-2.93-4.08-3.29-4.65-3.70
Net Income-4.59-2.46-4.47-2.93-4.08-3.29-4.65-3.70
EPS (Recurring)-0.62-0.41-0.85-0.64-0.99-1.04-1.51-1.53
EPS (Basic, Before Extraordinaries)-0.62-0.41-0.85-0.64-0.99-1.04-1.51-1.64
EPS (Diluted)-0.62-0.41-0.85-0.64-0.99-1.04-1.51-1.64
EBITDA-3.21-1.11-3.10-1.58-2.55-1.99-3.44-1.83
Non-Operating Income (Expense)0.000.000.010.03-0.160.060.16-0.05
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense2.010.00-0.351.320.061.760.47
Price To Sales Ratio1,049.48462.9269.16139.61105.2273.37339.37132.94
Gross Margin-780,350.00-729,612.42-10,724.33-55,604.57-25,529.62-1,025.63--
Operating Margin---38,647.99-128,481.45-80,327.84-2,978.02--
Net Margin---40,182.54-135,288.51-87,604.33-3,093.98--
Shares Outstanding7.386.115.884.794.273.443.092.76
Market Capitalization3.479.717.8916.4912.088.467.036.62

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments0.423.891.891.851.750.020.411.281.98
Short Term Receivables0.000.000.000.200.000.000.000.000.00
Inventories0.300.140.170.600.000.000.000.000.02
Other Current Assets0.430.300.420.200.470.050.030.030.08
Total Current Assets1.144.342.472.852.220.080.451.302.08
Net Property, Plant & Equipment0.340.560.881.381.190.000.010.010.03
Total Investments and Advances0.000.000.000.000.000.000.000.000.00
Intangible Assets19.2323.7528.2832.8137.330.180.150.150.18
Other Assets0.160.170.210.080.090.000.000.000.00
Total Assets20.8728.8231.8437.1140.820.260.601.462.29
Short Term Debt Incl. Current Port. of LT Debt0.003.000.041.2629.590.950.440.510.89
Accounts Payable0.000.000.000.000.000.150.210.120.16
Other Current Liabilities1.080.951.291.211.000.000.100.100.78
Total Current Liabilities1.083.951.342.4730.591.100.750.731.82
Long Term Debt11.009.005.920.010.030.000.000.000.00
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Other Liabilities1.230.350.140.000.000.000.000.000.00
Total Liabilities13.3113.307.392.4830.631.100.750.731.82
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity7.5615.5224.4534.6310.20-0.84-0.160.730.47
Total Shareholders Equity7.5615.5224.4534.6310.20-0.84-0.160.730.47
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity7.5615.5224.4534.6310.20-0.84-0.160.730.47
Total Liabilities & Stockholders Equity20.8728.8231.8437.1140.820.260.601.462.29
Book Value Per Share1.295.0326.1343.2626.49-7.47-1.457.007.62
Tangible Book Value Per Share-1.98-2.67-4.102.28-70.47-9.08-2.805.594.67
Full-Time Employees41444643354464
Price to Book Ratio1.060.450.300.3311.89-8.53-77.5814.47-6.60
Return on Assets-59.45-49.00-39.94-35.95-18.93-338.57-153.50-71.25-44.79
Return on Equity-128.00-74.38-46.62-62.49-83.10--551.55-222.94-
Return on Invested Capital-79.57-60.63-45.34-40.44-38.02---183.36-131.13
Quick Ratio0.781.061.720.910.070.070.591.781.13
Current Ratio1.061.101.851.150.070.070.591.781.14

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-14.45-14.77-14.86-13.77-14.01-3.89-1.45-1.58-1.34
Depreciation4.774.784.804.874.832.040.010.020.06
Other Funds (Non Cash)4.494.654.224.026.420.150.520.400.13
Funds from Operations-5.19-5.34-5.85-4.88-2.75-1.69-0.91-1.16-1.15
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital0.720.730.040.19-0.270.440.410.250.15
Cash from Operating Activities-4.47-4.61-5.81-4.69-3.02-1.25-0.50-0.91-1.01
Capital Expenditures-0.02-0.03-0.13-0.10-0.63-0.14-0.01-0.01-0.01
Net Assets From Acquisitions0.000.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.000.00
Other Uses0.000.000.000.000.00-0.040.000.000.00
Other Sources0.040.030.000.000.000.000.000.000.00
Cash from Investing Activities0.02-0.00-0.13-0.10-0.63-0.18-0.01-0.01-0.01
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock1.892.010.000.001.780.060.000.130.40
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock1.892.010.000.001.780.060.000.130.40
Proceedsfrom Stock Options1.892.010.000.000.000.000.000.130.40
Issuance or Reduction of Debt, Net2.81-1.008.034.922.073.100.12-0.07-0.20
Change in Long Term Debt2.81-1.008.033.610.000.000.000.000.00
Issuance of Long Term Debt2.810.009.784.000.000.000.000.000.00
Reduction of Long Term Debt0.00-1.00-1.75-0.390.000.000.000.000.00
Net Financing Active Other Cash Flow0.00-0.000.00-0.00-0.020.000.000.000.05
Other Financing Activities Uses0.00-0.000.00-0.00-0.020.000.000.000.00
Cash from Financing Activities4.701.018.034.923.833.150.120.050.25
Exchange Rate Effect-0.060.13-0.08-0.10-0.080.01---
Net Change in Cash0.20-3.482.010.030.101.73-0.39-0.87-0.76
Free Cash Flow-4.49-4.65-5.83-4.79-3.66-1.39-0.50-0.91-1.01
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Cash & Short Term Investments1.422.840.421.131.222.63
Short Term Receivables0.000.000.000.000.000.00
Inventories0.310.320.300.170.160.14
Other Current Assets0.460.360.430.430.350.28
Total Current Assets2.193.521.141.721.733.05
Net Property, Plant & Equipment0.240.290.340.410.500.49
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets16.9818.1119.2320.3721.5122.63
Other Assets0.150.160.160.180.190.17
Total Assets19.5622.0820.8722.6823.9226.35
Short Term Debt Incl. Current Port. of LT Debt13.814.810.000.000.001.00
Accounts Payable0.000.000.000.000.000.00
Other Current Liabilities2.461.531.080.580.600.52
Total Current Liabilities16.286.351.080.580.601.52
Long Term Debt0.009.0011.0011.0011.0011.00
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities0.001.041.231.050.880.71
Total Liabilities16.2816.3913.3112.6312.4813.23
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity3.285.697.5610.0411.4413.12
Total Shareholders Equity3.285.697.5610.0411.4413.12
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity3.285.697.5610.0411.4413.12
Total Liabilities & Stockholders Equity19.5622.0820.8722.6823.9226.35
Book Value Per Share0.440.931.292.102.683.81
Tangible Book Value Per Share-1.86-2.03-1.98-2.15-2.36-2.76
Full-Time Employees--41---
Price to Book Ratio1.061.080.781.291.060.64
Return on Assets-66.48-57.58-59.45-55.34-52.89-52.88
Return on Equity-196.30-148.24-128.00-106.58-97.80-82.87
Return on Invested Capital-139.91-16.74-24.07-13.93-18.20-13.62
Quick Ratio0.120.500.782.672.611.91
Current Ratio0.130.551.062.962.882.00

Cash flow, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Net Income-4.59-2.46-4.47-2.93-4.08-3.29
Depreciation1.191.171.201.211.191.18
Other Funds (Non Cash)2.160.001.910.421.400.92
Funds from Operations-1.25-1.29-1.36-1.30-1.49-1.19
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-0.200.300.500.120.14-0.03
Cash from Operating Activities-1.45-0.98-0.86-1.18-1.35-1.22
Capital Expenditures-0.01-0.010.00-0.010.01-0.03
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses8E-060.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.010.010.010.02-0.010.01
Cash from Investing Activities0.01-0.000.010.000.00-0.02
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.000.600.161.130.700.01
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.000.600.161.130.700.01
Proceedsfrom Stock Options0.000.600.161.130.700.01
Issuance or Reduction of Debt, Net0.002.810.000.00-1.000.00
Change in Long Term Debt0.002.810.000.00-1.000.00
Issuance of Long Term Debt0.002.810.000.000.000.00
Reduction of Long Term Debt0.000.000.000.00-1.000.00
Net Financing Active Other Cash Flow0.000.000.000.00-0.000.00
Other Financing Activities Uses0.000.000.000.00-0.000.00
Cash from Financing Activities0.003.410.161.13-0.300.01
Exchange Rate Effect0.02-0.01-0.02-0.050.24-0.03
Net Change in Cash-1.422.42-0.71-0.09-1.41-1.26
Free Cash Flow-1.45-0.99-0.85-1.19-1.34-1.26

Revenue breakdown

Computer Peripheral Equipment, NEC2024: 20.73K 2025: 124.16K
United States2024: 20.73K 2025: 124.16K

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-302.05%0.0M1.8M187.15K
2026-10-152.57%0.0M1.8M189.01K
2026-09-302.25%0.0M1.8M194.68K
2026-09-153.05%0.1M1.8M96.18K
2026-08-311.12%0.0M1.8M100.71K
2026-08-141.38%0.0M1.8M419.41K
2026-07-311.16%0.0M1.8M360.14K
2026-07-150.67%0.0M2.1M363.52K
2026-06-300.67%0.0M2.1M352.52K
2026-06-150.88%0.0M2.1M345.93K
2026-05-294.33%0.1M2.1M344.03K
2026-05-151.25%0.0M1.9M30.16K
2026-04-301.19%0.0M1.8M49.19K
2026-04-151.92%0.0M1.6M651.70K
2026-03-310.77%0.0M2.9M650.01K
2026-03-131.19%0.0M2.7M649.17K
2026-02-273.05%0.1M2.7M639.49K
2026-02-133.62%0.1M2.7M637.35K
2026-01-3013.29%0.4M2.7M622.64K
2026-01-150.72%0.0M2.5M31.00K

Option chain

expiry 2026-11-11
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-10ARSAnnual report to security holders. 2025-12-31SEC
2026-11-10DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-11-10SEC
2026-10-168-KCurrent report2026-10-14SEC
2026-09-288-KCurrent report2026-09-24SEC
2026-08-038-KCurrent report2026-08-03SEC
2026-08-0310-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-07-24424B5SEC
2026-07-108-KCurrent report2026-07-09SEC
2026-07-098-KCurrent report2026-07-03SEC
2026-06-094Statement of changes in beneficial ownership of securities2026-06-05SEC
2026-06-054Statement of changes in beneficial ownership of securities2026-06-03SEC
2026-06-014Statement of changes in beneficial ownership of securities2026-05-28SEC
2026-05-294Statement of changes in beneficial ownership of securities2026-05-27SEC
2026-05-274Statement of changes in beneficial ownership of securities2026-05-26SEC
2026-05-274Statement of changes in beneficial ownership of securities2026-05-26SEC
2026-05-274Statement of changes in beneficial ownership of securities2026-05-22SEC
2026-05-264Statement of changes in beneficial ownership of securities2026-05-21SEC
2026-05-204Statement of changes in beneficial ownership of securities2026-05-18SEC
2026-05-1310-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-138-KCurrent report2026-05-13SEC
2026-05-074Statement of changes in beneficial ownership of securities2026-05-05SEC
2026-05-014Statement of changes in beneficial ownership of securities2026-04-29SEC
2026-04-17SCHEDULE 13D/ASEC
2026-04-17SCHEDULE 13D/ASEC
2026-04-17SCHEDULE 13D/ASEC
2026-04-174Statement of changes in beneficial ownership of securities2026-04-15SEC
2026-04-174Statement of changes in beneficial ownership of securities2026-04-15SEC
2026-04-174Statement of changes in beneficial ownership of securities2026-04-15SEC
2026-04-154Statement of changes in beneficial ownership of securities2026-04-12SEC
2026-04-15SCHEDULE 13D/ASEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-0611.44K200
2026-059.32K5387.89K6
2026-04511200
2026-030000
2026-020000
2026-0100102.14K3
2025-120000
2025-110000

Institutional holders

Manager% owned
GEODE CAPITAL MANAGEMENT, LLC0.59%
HRT FINANCIAL LP0.38%
Keystone Financial Group0.30%
VANGUARD CAPITAL MANAGEMENT LLC0.19%
Mariner, LLC0.19%
VANGUARD FIDUCIARY TRUST CO0.17%
JANE STREET GROUP, LLC0.13%
Tower Research Capital LLC0.04%
BlackRock, Inc.0.04%
CITIGROUP INC0.02%

Funds

Fund% owned
Fidelity Extended Market Index Fund0.31%
Fidelity Series Total Market Index Fund0.27%
VANGUARD EXTENDED MARKET INDEX FUND0.19%
Fidelity Nasdaq Composite Index Fund0.00%

OakChart. AIMD. Cached 15 minutes.

Some panels did not load: ratings.